Chitotriosidase as biomarker for early stage amyotrophic lateral sclerosis: a multicenter study
<p><strong>Objective:</strong> Levels of chitotriosidase (CHIT1) are increased in the cerebrospinal fluid (CSF) of amyotrophic lateral sclerosis (ALS) patients reflecting microglial activation. Here, we determine the diagnostic and prognostic potential of CHIT1 for early symptomati...
Main Authors: | Steinacker, P, Feneberg, E, Halbgebauer, S, Witzel, S, Verde, F, Oeckl, P, Van Damme, P, Gaur, N, Gray, E, Grosskreutz, J, Jardel, CG, Kachanov, M, Kuhle, J, Lamari, F, Maceski, A, del Mar Amador, M, Mayer, B, Morelli, C, Petri, S, Poesen, K, Raaphorst, J, Salachas, F, Silani, V, Turner, M, Verbeek, MM, Volk, AE, Weishaupt, JH, Weydt, P, Ludolph, AC, Otto, M |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Taylor and Francis
2021
|
Similar Items
-
Multicenter evaluation of neurofilaments in early symptomatic amyotrophic lateral sclerosis
by: Feneberg, E, et al.
Published: (2017) -
Chitotriosidase (CHIT1) is increased in microglia and macrophages in spinal cord of amyotrophic lateral sclerosis and cerebrospinal fluid levels correlate with disease severity and progression
by: Steinacker, P, et al.
Published: (2017) -
A multi-center study of neurofilament assay reliability and inter-laboratory variability
by: Gray, E, et al.
Published: (2020) -
Multicenter validation of CSF neurofilaments as diagnostic biomarkers for ALS
by: Oeckl, P, et al.
Published: (2016) -
Increased chitotriosidase 1 concentration following nusinersen treatment in spinal muscular atrophy
by: Maren Freigang, et al.
Published: (2021-07-01)